百濟神州(06160.HK)增持合營企業5%股權及償還股東貸款 共涉逾13億人幣
百濟神州(06160.HK)公布,於今年9月28日,旗下子公司與凱得訂立購股協議,以約1.95億元人民幣(下同)總購買價收購凱得所持有雙方合營公司百濟神州生物藥業的5%股權,及使百濟神州生物藥業悉數償還股東貸款及利息,總額約為11.5億元。
於此項交易完成後,公司將持有百濟神州生物藥業的100%股權,惟須經當地市場監督管理局批准,預期於今年第四季度取得;股東貸款已悉數償還並已終止,及公司與凱得訂立日期為2017年4月11日的經修訂百濟神州生物藥業股權合資合約將於監管批准日期終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.